Patent Assignment
Reel/Frame 064479/0178
Assignment of Assignor's Interest
Recorded: 2023-08-03
Pages: 11
Assignors
AMIT, INBAR
Executed: 2023-04-17
LEVIN, ITAY
Executed: 2023-04-17
CHEN, AYELET
Executed: 2023-04-17
VANA, TAL
Executed: 2023-04-17
OREN, NINO
Executed: 2023-04-17
ZADA, EFRAT CHOEN
Executed: 2023-04-17
LEVITIN, NATALIA
Executed: 2023-04-17
NIMROD, GUY
Executed: 2023-04-17
SASSON, YEHEZKEL
Executed: 2023-04-17
DEMISHTEIN, ALIK
Executed: 2023-04-17
WYANT, TIMOTHY
Executed: 2023-04-17
FUCHS, REUT BARAK
Executed: 2023-04-17
FASTMAN, YAIR
Executed: 2023-04-17
FISCHMAN, SHARON
Executed: 2023-04-17
ZHENIN, MICHAEL
Executed: 2023-04-17
YERMOLAEV, OLGA BLUVSHTEIN
Executed: 2023-04-17
GROSSMAN, NOAM
Executed: 2023-04-17
TWITO, OSHRAT SHIR
Executed: 2023-04-17
BITON, NEVET ZUR
Executed: 2023-04-17
DANIELPUR, LIRON
Executed: 2023-04-17
BEN MAYOR, MAY SOFIA
Executed: 2023-04-17
OFRAN, YANAY
Executed: 2023-04-17
SAMET, DOR
Executed: 2023-04-17
STRAJBL, MAREK
Executed: 2023-04-17
Assignee
BIOLOJIC DESIGN LTD.
HAMADA 12, BUILDING B, 3RD FLOOR, P.O. BOX 4106, REHOVOT, 7670316, ISRAEL
Covered Property
(1)
Anti-Tumor Necrosis Factor Receptor (TNFR2) Antibodies and Uses Thereof
Application:
18/011,251 →
Publication:
US 2023/0167188
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.